Latest News

Are you on an Infusion Treatment?

May 30, 2024 | Advocacy, Treatments

At MSNZ we would like to understand more about patient experiences with infusion treatments. The first line Disease Modifying Treatment (DMT) options we have been successful in advocating for in NZ are considered some of the best in the world. […]


Update: Siponimod (Mayzent) for Secondary Progressive MS

November 16, 2022 | Advocacy, Funding, Treatments

At the August 2022 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC), Multiple Sclerosis NZ (MSNZ) made a submission in support of the funding of Siponimod (Mayzent) for Secondary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested further advice from the […]


Calling all people with Secondary Progressive MS

July 26, 2022 | Life with MS, Progressive, Research

Multiple Sclerosis NZ is currently in the process of providing information to Pharmac regarding the high unmet need of those with Secondary Progressive MS. A new treatment, Siponimod (Mayzent), is currently under review and due to be assessed by PTAC […]


ECTRIMS 2021 Conference Review

November 3, 2021 | Education, Event, Progressive, Uncategorised

The 37th Congress of the European Committee for Treatment and Research in MS (ECTRIMS) was held online recently. The scientific programme comprised well-known session formats such as Scientific Sessions, Hot Topics and Meet the Experts, as well as live discussions […]